| Dr Whitney D Tope, MD | |
|
6545 France Ave S Ste 564, Edina, MN 55435-2125 | |
| (952) 746-6090 | |
| (952) 224-1204 |
| Full Name | Dr Whitney D Tope |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 36 Years |
| Location | 6545 France Ave S Ste 564, Edina, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770506784 | NPI | - | NPPES |
| 390822400 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 38930 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pinnacle Dermatology Sc | 8628353380 | 160 |
News Archive
A new study published by The University of Western Ontario reveals that couples who share the responsibility for paid and unpaid work report higher average measures of happiness and life satisfaction than those in other family models.
The study, conducted by a team of more than 200 scientists from 100 institutions worldwide, measured the size of the brain and its memory centers in thousands of MRI images from 21,151 healthy people while simultaneously screening their DNA. According to the researchers, a variant in a gene called HMGA2 affected the brain size, as well as a person's intelligence.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces today that the positive microplasmin Phase II trial results, evaluating the product's efficacy and safety in patients who require vitrectomy, have been published in the prestigious American Academy of Ophthalmology's Journal, Ophthalmology, the leading journal for the vitreoretinal community.
Angeles suffers from a severe and rare genetic disease called Acute Intermittent Porphyria (AIP). This means, one of her genes restrains her liver to produce a specific protein needed for the metabolism of the blood. During an AIP attack Angeles usually feels intense abdominal pain, and her mental status changes. Women live at an increased risk to trigger the symptoms, because porphyria is related to the menstrual cycle.
Depomed, Inc. announced today top-line results from the BREEZE 1 and 2 Phase 3 clinical trials evaluating the safety and efficacy of SeradaTM, an investigational non-hormonal extended release formulation of gabapentin for the treatment of menopausal hot flashes.
› Verified 1 days ago
| Entity Name | Dermatology Professionals, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720269426 PECOS PAC ID: 4587753934 Enrollment ID: O20071207000626 |
News Archive
A new study published by The University of Western Ontario reveals that couples who share the responsibility for paid and unpaid work report higher average measures of happiness and life satisfaction than those in other family models.
The study, conducted by a team of more than 200 scientists from 100 institutions worldwide, measured the size of the brain and its memory centers in thousands of MRI images from 21,151 healthy people while simultaneously screening their DNA. According to the researchers, a variant in a gene called HMGA2 affected the brain size, as well as a person's intelligence.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces today that the positive microplasmin Phase II trial results, evaluating the product's efficacy and safety in patients who require vitrectomy, have been published in the prestigious American Academy of Ophthalmology's Journal, Ophthalmology, the leading journal for the vitreoretinal community.
Angeles suffers from a severe and rare genetic disease called Acute Intermittent Porphyria (AIP). This means, one of her genes restrains her liver to produce a specific protein needed for the metabolism of the blood. During an AIP attack Angeles usually feels intense abdominal pain, and her mental status changes. Women live at an increased risk to trigger the symptoms, because porphyria is related to the menstrual cycle.
Depomed, Inc. announced today top-line results from the BREEZE 1 and 2 Phase 3 clinical trials evaluating the safety and efficacy of SeradaTM, an investigational non-hormonal extended release formulation of gabapentin for the treatment of menopausal hot flashes.
› Verified 1 days ago
| Entity Name | Minnesota Dermatology, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609009380 PECOS PAC ID: 1658418181 Enrollment ID: O20091102000251 |
News Archive
A new study published by The University of Western Ontario reveals that couples who share the responsibility for paid and unpaid work report higher average measures of happiness and life satisfaction than those in other family models.
The study, conducted by a team of more than 200 scientists from 100 institutions worldwide, measured the size of the brain and its memory centers in thousands of MRI images from 21,151 healthy people while simultaneously screening their DNA. According to the researchers, a variant in a gene called HMGA2 affected the brain size, as well as a person's intelligence.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces today that the positive microplasmin Phase II trial results, evaluating the product's efficacy and safety in patients who require vitrectomy, have been published in the prestigious American Academy of Ophthalmology's Journal, Ophthalmology, the leading journal for the vitreoretinal community.
Angeles suffers from a severe and rare genetic disease called Acute Intermittent Porphyria (AIP). This means, one of her genes restrains her liver to produce a specific protein needed for the metabolism of the blood. During an AIP attack Angeles usually feels intense abdominal pain, and her mental status changes. Women live at an increased risk to trigger the symptoms, because porphyria is related to the menstrual cycle.
Depomed, Inc. announced today top-line results from the BREEZE 1 and 2 Phase 3 clinical trials evaluating the safety and efficacy of SeradaTM, an investigational non-hormonal extended release formulation of gabapentin for the treatment of menopausal hot flashes.
› Verified 1 days ago
| Entity Name | Pinnacle Dermatology Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861930984 PECOS PAC ID: 8628353380 Enrollment ID: O20200715003001 |
News Archive
A new study published by The University of Western Ontario reveals that couples who share the responsibility for paid and unpaid work report higher average measures of happiness and life satisfaction than those in other family models.
The study, conducted by a team of more than 200 scientists from 100 institutions worldwide, measured the size of the brain and its memory centers in thousands of MRI images from 21,151 healthy people while simultaneously screening their DNA. According to the researchers, a variant in a gene called HMGA2 affected the brain size, as well as a person's intelligence.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces today that the positive microplasmin Phase II trial results, evaluating the product's efficacy and safety in patients who require vitrectomy, have been published in the prestigious American Academy of Ophthalmology's Journal, Ophthalmology, the leading journal for the vitreoretinal community.
Angeles suffers from a severe and rare genetic disease called Acute Intermittent Porphyria (AIP). This means, one of her genes restrains her liver to produce a specific protein needed for the metabolism of the blood. During an AIP attack Angeles usually feels intense abdominal pain, and her mental status changes. Women live at an increased risk to trigger the symptoms, because porphyria is related to the menstrual cycle.
Depomed, Inc. announced today top-line results from the BREEZE 1 and 2 Phase 3 clinical trials evaluating the safety and efficacy of SeradaTM, an investigational non-hormonal extended release formulation of gabapentin for the treatment of menopausal hot flashes.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Whitney D Tope, MD 820 Springer Dr, Lombard, IL 60148-6413 Ph: (815) 744-8554 | Dr Whitney D Tope, MD 6545 France Ave S Ste 564, Edina, MN 55435-2125 Ph: (952) 746-6090 |
News Archive
A new study published by The University of Western Ontario reveals that couples who share the responsibility for paid and unpaid work report higher average measures of happiness and life satisfaction than those in other family models.
The study, conducted by a team of more than 200 scientists from 100 institutions worldwide, measured the size of the brain and its memory centers in thousands of MRI images from 21,151 healthy people while simultaneously screening their DNA. According to the researchers, a variant in a gene called HMGA2 affected the brain size, as well as a person's intelligence.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces today that the positive microplasmin Phase II trial results, evaluating the product's efficacy and safety in patients who require vitrectomy, have been published in the prestigious American Academy of Ophthalmology's Journal, Ophthalmology, the leading journal for the vitreoretinal community.
Angeles suffers from a severe and rare genetic disease called Acute Intermittent Porphyria (AIP). This means, one of her genes restrains her liver to produce a specific protein needed for the metabolism of the blood. During an AIP attack Angeles usually feels intense abdominal pain, and her mental status changes. Women live at an increased risk to trigger the symptoms, because porphyria is related to the menstrual cycle.
Depomed, Inc. announced today top-line results from the BREEZE 1 and 2 Phase 3 clinical trials evaluating the safety and efficacy of SeradaTM, an investigational non-hormonal extended release formulation of gabapentin for the treatment of menopausal hot flashes.
› Verified 1 days ago
Dr. Amanda Joy Tschetter, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3316 W 66th St, Edina, MN 55435 Phone: 952-920-3808 | |
Dr. Mimi Cho, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3316 W 66th St, Suite 200, Edina, MN 55435 Phone: 952-920-3808 Fax: 952-920-8899 | |
Dr. Patrick Carney, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 7373 France Ave S Ste 110, Edina, MN 55435 Phone: 952-831-8228 Fax: 952-831-0822 | |
Dr. Jennifer Emily Dick, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3316 W 66th St, Suite 200, Edina, MN 55435 Phone: 952-920-3808 Fax: 952-920-8899 | |
Dr. Arthur W Ide Iii, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 7300 France Ave So, Suite 400, Edina, MN 55435 Phone: 952-374-5995 Fax: 952-374-5997 | |
Dr. Marie Elizabeth Briden, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6525 Barrie Rd, Edina, MN 55435 Phone: 952-915-6000 Fax: 952-915-6100 | |
Dr. Cally Chermak, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3316 W 66th St, Ste 200, Edina, MN 55435 Phone: 952-920-3808 Fax: 952-920-8899 |